The role of intraocular methotrexate in the management of uveitis and posterior segment involvement in Behçet’s disease patients

Behçet, 1937, Uber rezidivierende Aphtose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien, Dermatol Wochenschr, 105, 1152 International Study Group for Behçet’s Disease, 1990, Criteria for diagnosis of Behçet’s disease, Lancet, 335, 1078 Kaçmaz, 2008, Systemic immunosuppressive therapy for eye diseases cohort study group: ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity, Am J Ophthalmol, 146, 828, 10.1016/j.ajo.2008.06.019 Couch, 2009, Intravitreal triamcinolone for intraocular inflammation and associated macular edema, Clin Ophthalmol, 3, 41 Toker, 2002, High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet’s disease, Br J Ophthalmol, 86, 521, 10.1136/bjo.86.5.521 Benezra, 1986, Treatment and visual prognosis in Behçet’s disease, Br J Ophthalmol, 70, 589, 10.1136/bjo.70.8.589 Tugal-Tutkun, 2009, Behçet’s uveitis, Middle East Afr J Ophthalmol, 16, 219 Allegra, 1987, Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate, J Biol Chem, 262, 13520, 10.1016/S0021-9258(19)76458-8 de Smet, 1999, Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma, Br J Ophthalmol, 83, 448, 10.1136/bjo.83.4.448 Bhakta, 1999, Behcet’s disease: evaluation of a new instrument to measure clinical activity, Rheumatology (Oxford), 38, 728, 10.1093/rheumatology/38.8.728 Tabbara, 2008, Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease, Am J Ophthalmol, 146, 845, 10.1016/j.ajo.2008.09.010 Jabs, 2005, Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop, Am J Ophthalmol, 140, 509, 10.1016/j.ajo.2005.03.057 Charteris, 1992, Behçet’s disease: activated T lymphocytes in retinal perivasculitis, Br J Ophthalmol, 76, 499, 10.1136/bjo.76.8.499 Yu, 2004, The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet’s uveitis, Clin Exp Immunol, 137, 437, 10.1111/j.1365-2249.2004.02536.x Ilhan, 2008, Th1 polarization of the immune response in uveitis in Behçet’s disease, Can J Ophthalmol, 43, 105, 10.3129/i07-179 Cannella, 2008, Methotrexate, leflunomide, sulfasalazine, hydroxychloroquine, and combination therapies, 883 Szabó, 1998, Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists, Br J Pharmacol, 125, 379, 10.1038/sj.bjp.0702040 Bouma, 1994, Differential regulatory effects of adenosine on cytokine release by activated human monocytes, J Immunol, 153, 4159, 10.4049/jimmunol.153.9.4159 Kim, 2009, A case of primary intraocular lymphoma treated by intravitreal methotrexate, Korean J Ophthalmol, 23, 210, 10.3341/kjo.2009.23.3.210 Gangaputra, 2009, Systemic immunosuppressive therapy for eye diseases cohort study: methotrexate for ocular inflammatory diseases, Ophthalmology, 116, 2188, 10.1016/j.ophtha.2009.04.020 Hardwig, 2006, Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma, Am J Ophthalmol, 142, 883, 10.1016/j.ajo.2006.06.002 Chan, 2004, Intraocular lymphoma: update on diagnosis and management, Cancer Control, 11, 285, 10.1177/107327480401100502 Taylor, 2009, Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema, Ophthalmology, 116, 797, 10.1016/j.ophtha.2008.10.033 Taylor, 2013, Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis, Retina, 33, 2149, 10.1097/IAE.0b013e31828ac07d Bae, 2012, Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behçet disease, Retina, 32, 1395, 10.1097/IAE.0b013e31823496a3